|
29
|
112
|
6fivA |
Structural studies of hiv and fiv proteases complexed with an efficient inhibitor of fiv pr |
|
88
|
325
|
6aprE |
Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors |
|
21
|
131
|
5c9bA |
Crystal structure of a retropepsin-like aspartic protease from rickettsia conorii |
|
17
|
99
|
5b18A |
Crystal structure of a darunavir resistant hiv-1 protease |
|
24
|
132
|
5c9fA |
Crystal structure of a retropepsin-like aspartic protease from rickettsia conorii |
|
19
|
127
|
5c9dA |
Crystal structure of a retropepsin-like aspartic protease from rickettsia conorii |
|
81
|
376
|
5bwyA |
Structure of proplasmepsin ii from plasmodium falciparum, space group p43212 |
|
18
|
99
|
5bs4A |
Hiv-1 wild type protease with grl-047-11a (a methylamine bis-tetrahydrofuran p2-ligand, 4-amino sulfonamide derivative) |
|
18
|
99
|
5bryA |
Hiv-1 wild type protease with grl-011-11a (a methylamine bis-tetrahydrofuran p2-ligand, sulfonamide isostere derivate) |
|
81
|
330
|
4ze6A |
Endothiapepsin in complex with fragment b39 |
|
18
|
99
|
4zlsA |
Hiv-1 wild type protease with grl-096-13a (a boc-derivative p2-ligand, 3,-5-dimethylbiphenyl p1-ligand) |
|
18
|
99
|
4zipA |
Hiv-1 wild type protease with grl-0648a (a isophthalamide-derived p2-ligand) |
|
20
|
99
|
4z50A |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20d25n with tucked flap |
|
83
|
330
|
4ycyA |
Endothiapepsin in complex with fragment 218 |
|
15
|
99
|
4z4xA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20d25n with open flap |
|
25
|
136
|
4z2zA |
New crystal structure of yeast ddi1 aspartyl protease reveals substrate engagement mode |
|
98
|
334
|
4ybfA |
Aspartic proteinase sapp2 secreted from candida parapsilosis at 1.25 a resolution |
|
19
|
99
|
4qjaA |
Crystal structure of inactive hiv-1 protease in complex with p1-p6 substrate variant (p453l) |
|
99
|
386
|
4exgA |
Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors |
|
45
|
203
|
4qlhA |
Crystal structure of drug resistant v82s/v1082s hiv-1 protease |
|
17
|
99
|
4eyrA |
Crystal structure of multidrug-resistant clinical isolate 769 hiv-1 protease in complex with ritonavir |
|
17
|
99
|
4faeA |
Substrate p2/nc in complex with a human immunodeficiency virus type 1 protease variant |
|
81
|
330
|
4er2E |
The active site of aspartic proteinases |
|
44
|
203
|
4ep3A |
Crystal structure of inactive single chain wild-type hiv-1 protease in complex with the substrate ca-p2 |
|
80
|
330
|
4er1E |
The active site of aspartic proteinases |
|
18
|
99
|
4f74A |
Crystal structure of active hiv-1 protease in complex with the n terminal product of the substrate ma-ca. |
|
18
|
99
|
4f75A |
Crystal structure of active hiv-1 protease in complex with the n terminal product of the substrate rh-in |
|
99
|
386
|
4ewoA |
Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors |
|
20
|
114
|
4exhA |
The crystal structure of xmrv protease complexed with acetyl-pepstatin |
|
18
|
99
|
4f76A |
Crystal structure of the active hiv-1 protease in complex with the products of p1-p6 substrate |
|
19
|
99
|
4f73A |
Crystal structure of active hiv-1 protease in complex with the n terminal product of ca-p2 cleavage site |
|
17
|
99
|
4fafA |
Substrate ca/p2 in complex with a human immunodeficiency virus type 1 protease variant |
|
43
|
203
|
4eqjA |
Crystal structure of inactive single chain variant of hiv-1 protease in complex with the substrate rt-rh |
|
17
|
99
|
4ej8A |
Apo hiv protease (pr) dimer in closed form with fragment 1f1 in the outside/top of flap |
|
18
|
99
|
4dqfA |
Crystal structure of (g16a/l38a) hiv-1 protease in complex with drv |
|
42
|
203
|
4eq0A |
Crystal structure of inactive single chain variant of hiv-1 protease in complex with the substrate p2-nc |
|
18
|
99
|
4ejlA |
Apo hiv protease (pr) dimer in closed form with fragment 1f1-n in the outside/top of flap |
|
94
|
388
|
4dvfA |
Crystal structure of bace1 with its inhibitor |
|
99
|
387
|
4dpfA |
Bace-1 in complex with a hea-macrocyclic type inhibitor |
|
43
|
203
|
4ep2A |
Crystal structure of inactive single chain wild-type hiv-1 protease in complex with the substrate rt-rh |
|
19
|
99
|
4dqcA |
Crystal structure of (g16c/l38c) hiv-1 protease in complex with drv |
|
18
|
99
|
4dqbA |
Crystal structure of wild-type hiv-1 protease in complex with drv |
|
65
|
330
|
4er4E |
High-resolution x-ray analyses of renin inhibitor-aspartic proteinase complexes |
|
19
|
99
|
4ejdA |
Hiv protease (pr) dimer in closed form with pepstatin in active site and fragment 1f1 in the outside/top of flap |
|
97
|
387
|
4dpiA |
Bace-1 in complex with hea-macrocyclic inhibitor, mv078512 |
|
44
|
203
|
4epjA |
Crystal structure of inactive single chain wild-type hiv-1 protease in complex with the substrate p2-nc |
|
54
|
293
|
4ehcA |
Crystal structure of the c-terminal domain of rv0977 of mycobacterium tuberculosis |
|
20
|
99
|
4dqhA |
Crystal structure of (r14c/e65c) hiv-1 protease in complex with drv |
|
91
|
387
|
4dusA |
Structure of bace-1 (beta-secretase) in complex with n-((2s,3r)-1-(4-fluorophenyl)-3-hydroxy-4-((6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridin]-4'-yl)amino)butan-2-yl)acetamide |
|
19
|
99
|
4dqeA |
Crystal structure of (g16c/l38c) hiv-1 protease in complex with drv |
